Togaviridae Disease Overview

Save information for later
Sign Up

Learn About Togaviridae Disease

What is the definition of Togaviridae Disease?
Togaviridae disease is a term used to describe a family of viruses grouped into two categories: Alphavirus and Rubivirus. Alphaviruses are spread primarily by mosquitoes and other insects, spiders, or crustaceans to humans and cause arthritis and encephalitis. Rubivirus, commonly known as Rubella, causes the childhood disease and is transmitted through airborne aerosol droplets.
What are the symptoms of Togaviridae Disease?
Symptoms of alphaviruses can include flu-like symptoms, fever, arthritis, headache, pain, muscle pain, rash, encephalitis, and/or other further complications. Symptoms of Rubella include fever, joint pain, headache, rash, and swollen glands (lymph nodes).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Togaviridae Disease?
Treatment for Togaviridae disease is mainly supportive care that addresses symptoms or complications. Other methods of prevention include vector-control and protecting against mosquito bites.
Who are the top Togaviridae Disease Local Doctors?
Johan Neyts
Elite in Togaviridae Disease
Johan Neyts
Elite in Togaviridae Disease
Johan Neyts

Immunology And Transplantation, VirusBank Platform, KU Leuven

Leuven, VLG, BE 

Johan Neyts practices in Leuven, Belgium. Mr. Neyts is rated as an Elite expert by MediFind in the treatment of Togaviridae Disease. His top areas of expertise are Yellow Fever, Hepatitis E, Viral Hemorrhagic Fever, Parainfluenza Virus Type 3, and Lung Transplant.

Donald J. Weaver
Advanced in Togaviridae Disease
Dr. Donald J. Weaver
Pediatric Nephrology
Advanced in Togaviridae Disease
Dr. Donald J. Weaver
Pediatric Nephrology

Atrium Health Levine Children's Nephrology

1001 Blythe Blvd., Suite C, 
Charlotte, NC 
704-381-8800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Donald Weaver is a Pediatric Nephrologist in Charlotte, North Carolina. Dr. Weaver is rated as an Advanced provider by MediFind in the treatment of Togaviridae Disease. His top areas of expertise are Posterior Urethral Valves, Togaviridae Disease, Feingold Syndrome, and Congenital Nephrotic Syndrome. Dr. Weaver is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Togaviridae Disease
Annette Mankertz
Elite in Togaviridae Disease
Annette Mankertz
Berlin, BE, DE 

Annette Mankertz practices in Berlin, Germany. Ms. Mankertz is rated as an Elite expert by MediFind in the treatment of Togaviridae Disease. Her top areas of expertise are Rubella, Mumps, Togaviridae Disease, and Parainfluenza.

View All Doctors
What are the latest Togaviridae Disease Clinical Trials?
A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, Lot-to-lot Consistency, 4-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, Lot-to-lot Consistency, 4-arm Study to Investigate the Safety and Immunogenicity of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
Enrollment Status: Recruiting
Publish Date: January 23, 2026
Intervention Type: Biological
Study Phase: Phase 3

Summary: This is a phase 3 randomized, modified double-blind study which purpose is to measure whether 3 lots of the investigational pneumococcal vaccine PCV21 can help the body to develop germ-fighting agents called antibodies (immunogenicity) in a similar way (ie, same immune response) when they are given in infants aged from approximately 2 months (42 to 89 days) and are safe compared to a licensed 20-v...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Enrollment Status: Recruiting
Publish Date: January 22, 2026

Summary: RACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capacity often obscure etiologies and transmission dynamics. This knowledge gap hinders the design of effective prevention and control strategies. RACSMEI will improve understanding across multiple pathogens using a multidisciplinary One Health...

View All Clinical Trials